DiscoverAxiom CatalystRare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)
Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

Update: 2025-02-26
Share

Description

Marissa McPhillips met Michelle, in her capacity as CEO of Alltrna, for a constructive conversation around the critical role industry plays in developing innovative treatments for rare disease. We heard how it takes an environment that supports innovation, with incentives, novel clinical trial designs, and other enabling regulations – with Michelle urging the rare disease community to continue to push for these things.

For more information about Alltrna and how they are scaling rare disease drug development by pioneering tRNA medicines to treat Stop Codon Disease, check out their LinkedIn pageYouTube channel, and X account (formerly Twitter).

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

Axiom Healthcare Strategies